Christine M McMahon

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Allogeneic Hematopoietic Stem Cell Transplantation

Acute Myeloid Leukemia

Tyrosine Kinase

Top Venues

Leukemia & lymphoma

Expert review of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Kellen B Gil, Diana Abbott, Maria L Amaya, Marc Schwartz, Jonathan A Gutman, Andrew Kent, Grace Bosma, Daniel A Pollyea, Christine M McMahon
Response to intensive induction chemotherapy after failure of frontline azacitidine and venetoclax in acute myeloid leukemia. Leukemia & lymphoma (2024)
Natalia J Gurule, Kenneth C Malcolm, Chelsea Harris, Jennifer R Knapp, Brian P O'Connor, Jazalle McClendon, William J Janssen, Frank Fang Yao Lee, Caitlin Price, Jackson Osaghae-Nosa, Emily A Wheeler, Christine M McMahon, Eric M Pietras, Daniel A Pollyea, Scott Alper
Myelodysplastic neoplasm-associated U2AF1 mutations induce host defense defects by compromising neutrophil chemotaxis. Leukemia (2023)
Shanshan Pei, Ian T Shelton, Austin E Gillen, Brett M Stevens, Maura Gasparetto, Yanan Wang, Lina Liu, Jun Liu, Tonya M Brunetti, Krysta Engel, Sarah Staggs, William Showers, Anagha Inguva Sheth, Maria L Amaya, Mohammad Minhajuddin, Amanda C Winters, Sweta B Patel, Hunter Tolison, Anna E Krug, Tracy N Young, Jeffrey Schowinsky, Christine M McMahon, Clayton A Smith, Daniel A Pollyea, Craig T Jordan
A novel type of monocytic leukemia stem cell revealed by the clinical use of venetoclax-based therapy. Cancer discovery (2023)
Rory Michael Shallis, Maximilian Stahl, Wei Wei, Pau Montesinos, Etienne Lengline, Judith Neukirchen, Vijaya R Bhatt, Mikkael A Sekeres, Amir T Fathi, Heiko Konig, Selina Luger, Irum Khan, Gail J Roboz, Thomas Cluzeau, David Martínez-Cuadron, Emmanuel Raffoux, Ulrich Germing, Jayadev Manikkam Umakanthan, Sudipto Mukhereje, Andrew M Brunner, Adam Miller, Christine M McMahon, Ellen K Ritchie, Rebeca Rodríguez-Veiga, Raphaël Itzykson, Blanca Boluda, Florence Rabian, María Del Mar Tormo Díaz, Evelyn Acuña-Cruz, Emma Rabinovich, Brendan Yoo, Isabel Cano, Nikolai A Podoltsev, Jan Philipp Bewersdorf, Steven Gore, Amer M Zeidan
Patterns of care and clinical outcomes of patients with newly diagnosed acute myeloid leukemia presenting with hyperleukocytosis who do not receive intensive chemotherapy. Leukemia & lymphoma 61 (5) (2020)
Christine M McMahon, Jonathan Canaani, Bryan Rea, Rachel L Sargent, Julianne N Qualtieri, Christopher D Watt, Jennifer J D Morrissette, Martin Carroll, Alexander E Perl
Gilteritinib induces differentiation in relapsed and refractory FLT3-mutated acute myeloid leukemia. Blood advances 3 (10) (2020)
Christine M McMahon, Alexander E Perl
Gilteritinib for the treatment of relapsed and/or refractory FLT3-mutated acute myeloid leukemia. Expert review of clinical pharmacology 12 (9) (2019)